Literature DB >> 21341032

Simple methods for preparing recombinant adenoviruses for high-efficiency transduction of vascular cells.

S A Nicklin1, A H Baker.   

Abstract

Adenoviruses are icosahedral viruses 70-90 nm in diameter with a double-stranded, linear DNA genome of approx 36 kb. They are widely utilized in gene transfer protocols owing to their relative ease of genetic manipulation, ability to grow to high titres (10(9)-10(12) plaque forming units [pfu]/mL), and their ability to infect both dividing and nondividing cells efficiently. The latter reason makes them extremely suitable for investigations in vascular systems where the low proliferative indices of cells is a limiting factor for retroviral gene transfer.

Year:  1999        PMID: 21341032     DOI: 10.1385/1-59259-247-3:271

Source DB:  PubMed          Journal:  Methods Mol Med        ISSN: 1543-1894


  15 in total

1.  Identification of coagulation factor (F)X binding sites on the adenovirus serotype 5 hexon: effect of mutagenesis on FX interactions and gene transfer.

Authors:  Raul Alba; Angela C Bradshaw; Alan L Parker; David Bhella; Simon N Waddington; Stuart A Nicklin; Nico van Rooijen; Jerome Custers; Jaap Goudsmit; Dan H Barouch; John H McVey; Andrew H Baker
Journal:  Blood       Date:  2009-05-08       Impact factor: 22.113

2.  Selective inhibition of inhibitory kappa B kinase-beta abrogates induction of nitric oxide synthase in lipopolysaccharide-stimulated rat aortic smooth muscle cells.

Authors:  Almudena Bermejo Gomez; Christopher MacKenzie; Andrew Paul; Robin Plevin
Journal:  Br J Pharmacol       Date:  2005-09       Impact factor: 8.739

3.  Nuclear factor kappa B is involved in lipopolysaccharide-stimulated induction of interferon regulatory factor-1 and GAS/GAF DNA-binding in human umbilical vein endothelial cells.

Authors:  L Liu; A Paul; C J MacKenzie; C Bryant; A Graham; R Plevin
Journal:  Br J Pharmacol       Date:  2001-12       Impact factor: 8.739

4.  Cytokine upregulation of proteinase-activated-receptors 2 and 4 expression mediated by p38 MAP kinase and inhibitory kappa B kinase beta in human endothelial cells.

Authors:  E Ritchie; M Saka; C Mackenzie; R Drummond; C Wheeler-Jones; T Kanke; R Plevin
Journal:  Br J Pharmacol       Date:  2007-03-05       Impact factor: 8.739

5.  Dysregulation of cadherins in the intercalated disc of the spontaneously hypertensive stroke-prone rat.

Authors:  Margaret Anne Craig; Martin W McBride; Godfrey Smith; Sarah J George; Andrew Baker
Journal:  J Mol Cell Cardiol       Date:  2010-02-06       Impact factor: 5.000

6.  Protein kinase Cε-calcineurin cosignaling downstream of toll-like receptor 4 downregulates fibrosis and induces wound healing gene expression in cardiac myofibroblasts.

Authors:  Rui F D S Mesquita; Margaret A Paul; Aida Valmaseda; Asvi Francois; Rita Jabr; Shahzia Anjum; Michael S Marber; Vishwanie Budhram-Mahadeo; Richard J Heads
Journal:  Mol Cell Biol       Date:  2013-12-02       Impact factor: 4.272

7.  In vivo modulation of Nogo-B attenuates neointima formation.

Authors:  Angelika B Kritz; Jun Yu; Paulette L Wright; Song Wan; Sarah J George; Crawford Halliday; Ning Kang; William C Sessa; Andrew H Baker
Journal:  Mol Ther       Date:  2008-09-09       Impact factor: 11.454

8.  Adenoviral delivery of angiotensin-(1-7) or angiotensin-(1-9) inhibits cardiomyocyte hypertrophy via the mas or angiotensin type 2 receptor.

Authors:  Monica Flores-Muñoz; Bruno M D C Godinho; Abdulaziz Almalik; Stuart A Nicklin
Journal:  PLoS One       Date:  2012-09-20       Impact factor: 3.240

9.  Regulation of PP2AC carboxylmethylation and cellular localisation by inhibitory class G-protein coupled receptors in cardiomyocytes.

Authors:  Michael R Longman; Antonella Ranieri; Metin Avkiran; Andrew K Snabaitis
Journal:  PLoS One       Date:  2014-01-27       Impact factor: 3.240

10.  Kallikrein-related peptidase 8 is expressed in myocardium and induces cardiac hypertrophy.

Authors:  Buqing Cao; Qing Yu; Wei Zhao; Zhiping Tang; Binhai Cong; Jiankui Du; Jianqiang Lu; Xiaoyan Zhu; Xin Ni
Journal:  Sci Rep       Date:  2016-01-29       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.